Firstsource Group USA, Inc. v. First Hospital Laboratories, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Firstsource Group USA, Inc. v. First Hospital Laboratories, Inc.

Sort by

Viewing results 1‒25 of 70

News in-depthUS economy
Wave of corporate exits sends chill through Chicago
...In the first half of this year, there were 96 such “pro-Chicago” decisions....
August 1, 2022
FT Magazine
Prediction markets can tell the future. Why is the US so afraid of them?
...In 1983, he founded Aristotle Inc, a technology consultancy that sold voter data to political campaigns....
November 10, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
InterviewNew York City
‘No big company is coming to the city’: biotech developer bemoans New York’s status
...Asked about the city’s prospects of luring big life sciences groups, he replied: “It’s a joke. It’s a joke . . . Regeneron is not coming to the city. Merck’s not coming to the city....
July 7, 2022
Food & Beverage
Asia’s new food frontier: the rise of edible tech
...A version of this article was first published by Nikkei Asia on July 23. ©2022 Nikkei Inc. All rights reserved....
July 27, 2022
Coronavirus
J&J and Abbott flag potential vaccine and rapid test
...J&J was the first large pharmaceutical company to enter the race for a vaccine, in January....
March 30, 2020
Altria Group Inc
US agency sues to unwind Altria’s $12.8bn Juul investment
...Altria, the parent of Marlboro-owner Philip Morris USA, has ceased the sales and distribution services it had provided the San Francisco-based company....
April 2, 2020
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
News in-depthPharmaceuticals sector
Crispr puts first human in-body gene editing to test
...Rival biotech group Intellia Therapeutics plans to seek US approval for its own trial in the second half of 2020....
January 7, 2020
Due Diligence
US states give T-Mobile/Sprint merger a frosty reception Premium content
...DD’s Indap v NYU’s Damodaran: Is stock compensation good or bad?...
June 12, 2019
Equities
Markets Now - Monday 8th June 2020
...Campari will be hard hit by COVID-19 due to high On Trade exposure, especially in core markets of Italy and the USA....
June 8, 2020
US politics & policy
America’s deep divisions on display in abortion debate
...Sixty per cent of Americans believe abortion should be legal in the first trimester....
February 22, 2019
Rana Foroohar
A light shines on the concentration of power in Silicon Valley
...Cern, the European physics research laboratory....
July 22, 2018
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Alex McCaskey, a researcher at the US energy department’s Oak Ridge National Laboratory, compares the current state of the art to the first efforts to program classical computers in the 1950s and early 1960s...
September 3, 2018
News in-depthThe Big Read
Big Tech vs Big Pharma: the battle over US patent protection
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
October 16, 2017
Cyber Security
Hacking medical devices is the next big security concern
...Such connected devices have many benefits, says analyst Christian Renaud of IT research firm 451 Group....
November 8, 2017
World
Singapore defence giant brings smart tech to city streets Premium content
...A version of this article was first published by the Nikkei Asian Review on June 8 2018. ©2018 Nikkei Inc. All rights reserved....
June 17, 2018
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthUS & Canadian companies
US pharma Gilead faces pricing dilemma with new cancer treatment
...But the therapy is complex and expensive, with a process that involves extracting a patient’s blood cells in hospital, transporting the plasma — normally by air — to a laboratory, and re-engineering them...
August 29, 2017
The Big ReadDavid Crow
Cancer treatment: scaling up a vein-to-vein solution
...The first company that tried to commercialise a cell therapy, biotech group Dendreon, offers a cautionary tale....
June 12, 2017
News in-depthTechnology sector
Baidu bets its future on AI revolution
...The company is in partnership with the government to build the country’s first national AI research laboratory in Beijing....
August 30, 2017
Tobacco
FT Health: Diseases less neglected
...First generation immunotherapy drugs already on the market include Merck’s Keytruda, Roche’s Tecentriqy, and BMS’ Opdivo....
April 21, 2017
News in-depthWeek in Review
Week in Review, September 2
...The therapy is complex and involves extracting a patient’s blood cells in hospital, transporting the plasma to a laboratory, and re-engineering them before they are returned....
September 1, 2017
News in-depthThe Big Read
Biotechnology: the US-China dispute over genetic data
...At the same time, hackers believed to be state-sponsored Chinese have penetrated the laboratories, health insurers and hospitals where other valuable patient records reside....
July 31, 2017
ExplainerIPOs
Will Snap make it into the S&P 500 index?
...MSCI said Snap’s inclusion into the MSCI USA index would be assessed as part of the next semi-annual index review in May, but the group is also surveying market participants on whether governance considerations...
March 8, 2017
World
Philippines’ Ayala comes full circle with push into healthcare
...A version of this article was first published by the Nikkei Asian Review on February 23. Website | Subscribe. ©2016 Nikkei Inc. All rights reserved....
February 27, 2017
News in-depthThe Big Read
Gene therapy: A controversial cure
...Re-engineering cells When a patient undergoes Car-T therapy, doctors first extract millions of their T-cells, a type of white blood cell, and ship them to a laboratory where they are genetically modified...
July 24, 2016
US equities
Palo Alto Networks shares slump on slower sales growth
...The deal comes just months after Thermo snapped up Affymetrix for $1.3bn in a move that will help the company expand its array of laboratory equipment, which includes diagnostic tools for hospitals and mass...
May 27, 2016

Previous pagePage 1 of 3Next page